Science Market Update

Biomedical News: Charlie’s Law Opens Opportunities for Stem Cell Treatments in Texas

Posted by Rebecca Inch-Partridge on Thu, Nov 02, 2017

In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.

Read More

Tags: Texas A&M, Texas A&M Research, TAMU, Texas A&M Life Science Funding, Research equipment, biotech vendor show, Biotechnology Vendor Fair, pollution, BioResearch Product Faire, laboratory suppliers, Texas Medical Center, tmc, Human Stem Cell, Stem cell research, Biomedical Reearch

$8 M in Research Funding to Expand Stem Cell Trials at UC Davis

Posted by Rebecca Inch-Partridge on Mon, Oct 16, 2017

UC Davis has a long history of ground breaking stem cell research. Possible therapies studied range from advanced wound healing, treating HIV, and reduced vision loss to the regeneration of bone in otherwise non-healing fractures. Now The California Institute for Regenerative Medicine (CIRM) has awarded UC Davis Medical Center scientists nearly $8 million in research funding to launch a special clinical trials program in Sacramento. The goal of the grant is to accelerate the development and delivery of stem cell therapies in human patients.

Read More

Tags: UCD, UC Davis - Medical Center, Research Funding, Bioresearch Grant, BioResearch Product Faire, California, CA, Southwest Region, research grant, new research grant, laboratory equipment, laboratory equipment suppliers, Lab Supply, Current Biotechnology Events, Laboratory product sales, Stem cell research, Human Stem Cell, immunotherapy, laboratory tools

UCLA: Utilizing Patient's Own Cells for Individualized Stem Cell Therapies

Posted by Rebecca Partridge on Wed, Feb 08, 2017

Researchers at UCLA believe using the patient’s own cells to create stem cells for therapeutic purposes is the future of medicine. A recently published study by scientists at UCLA demonstrates how specialized proteins change the cellular characteristics of skin cells to create induced pluripotent stem cells. These stem cells have the ability to turn into any cell type within the body. Also at UCLA, a clinical trial which uses the baby’s own blood-forming stem cells to treat the immune deficiency condition ADA-SCID, better known as “bubble baby disease,” was recently awarded a $20M grant from the California Institute for Regenerative Medicine.

Read More

Tags: UCLA, University of California Los Angeles, Stem Cell, Human Stem Cell, Stem cell research, Biotechnology trade show, biotech vendor show

Human Stem Cell Mechanisms Better Understood by UNC Chapel Hill Study

Posted by Jennifer Nieuwkerk on Tue, Apr 09, 2013

Read More

Tags: NIH, NC, NSF, Research Funding, North Carolina, University of North Carolina, UNC, UNC-Chapel Hill, University of North Carolina at Chapel Hill, BioResearch Product Faire Event, laboratory equipment sales, laboratory equipment, Stem Cell, Chapel Hill, Human Stem Cell, Front Line event, 2013, 2014, Southern, Front Line

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News